Suppr超能文献

一份关于丙型肝炎消除的国家政策、计划及进展的2024年全球报告:来自33份肝炎消除概况的调查结果

A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles.

作者信息

Hiebert-Suwondo Lindsey, Manning Jana, Tohme Rania A, Buti Maria, Kondili Loreta A, Spearman C Wendy, Hajarizadeh Behzad, Turnier Victoria, Lazarus Jeffrey V, Grebely Jason, Dore Gregory J, Waked Imam, Ward John W

机构信息

Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.

Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.

出版信息

Lancet Gastroenterol Hepatol. 2025 Jul;10(7):685-700. doi: 10.1016/S2468-1253(25)00068-8. Epub 2025 May 20.

Abstract

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development for the elimination of viral hepatitis. To date, profiles from 33 countries and territories have been developed. These profiles reveal that 30 (91%) countries and territories have hepatitis C national action plans, 11 (33%) have systems to monitor hepatitis C-related mortality, 16 (48%) have systems to monitor hepatitis C incidence, and 18 (55%) have systems to track the number of people tested and treated. Some countries and territories continue to uphold barriers to hepatitis C treatment, with 12 (36%) still having partial or full restrictions on prescribing authority for non-specialists. Ten (30%) countries and territories have met the WHO 2025 diagnosis coverage target of 60%, five (15%) have met the treatment target of 50%, and seven (21%) have met the needle and syringe exchange target. Although there are examples of countries and territories across the income spectrum meeting these targets, policy development in low-income and middle-income countries and territories generally lags behind that in high-income countries and territories.

摘要

全球消除肝炎联盟的《国家肝炎消除概况》评估了各国在消除病毒性肝炎方面的数据、政策和项目发展状况。迄今为止,已编制了33个国家和地区的概况。这些概况显示,30个(91%)国家和地区制定了丙型肝炎国家行动计划,11个(33%)有监测丙型肝炎相关死亡率的系统,16个(48%)有监测丙型肝炎发病率的系统,18个(55%)有跟踪检测和治疗人数的系统。一些国家和地区继续对丙型肝炎治疗设置障碍,12个(36%)仍对非专科医生的处方权有部分或完全限制。10个(30%)国家和地区达到了世界卫生组织2025年60%的诊断覆盖率目标,5个(15%)达到了50%的治疗目标,7个(21%)达到了针头和注射器交换目标。尽管不同收入水平的国家和地区都有达到这些目标的例子,但低收入和中等收入国家及地区的政策制定总体上落后于高收入国家和地区。

相似文献

7
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.

本文引用的文献

1
Implementing a new HCV model of care for people who use drugs.为吸毒者实施一种新的丙型肝炎护理模式。
JHEP Rep. 2024 Jun 13;6(10):101145. doi: 10.1016/j.jhepr.2024.101145. eCollection 2024 Oct.
2
Estimating hepatitis C prevalence in the United States, 2017-2020.2017 - 2020年美国丙型肝炎患病率估算
Hepatology. 2025 Feb 1;81(2):625-636. doi: 10.1097/HEP.0000000000000927. Epub 2024 May 13.
6
WHO awards Egypt with gold tier status on the path to eliminate hepatitis C.世界卫生组织授予埃及在消除丙型肝炎道路上的黄金级地位。
Lancet Gastroenterol Hepatol. 2023 Dec;8(12):1073-1074. doi: 10.1016/S2468-1253(23)00364-3. Epub 2023 Oct 19.
7
Lessons Learned From Global Hepatitis C Elimination Programs.从全球丙型肝炎消除计划中吸取的经验教训。
J Infect Dis. 2024 May 8;229(Supplement_3):S334-S341. doi: 10.1093/infdis/jiad198.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验